Osler, Hoskin & Harcourt LLP advised Waabi in its launch and Series A financing round. On June 8, 2021, Waabi announced its launch to build the...
Waabi’s $83.5 Million Series A Financing Round
7Shifts’ $21.5 Million Series B Financing
Osler, Hoskin & Harcourt LLP advised 7Shifts and Ten Coves Capital. On May 25, 2021, 7Shifts completed its US$21.5 million Series B financing round led by...
Genesis Fertilizers’ $1.5 Billion Urea Production and Distribution System
Osler, Hoskin & Harcourt LLP advised Genesis Fertilizers Limited Partnership. On May 12, 2021, Genesis Fertilizers Limited Partnership announced its plans to finance, design and construct a...
Troika Media Group’s $12.3 Million Acquisition of Redeeem
Osler, Hoskin & Harcourt LLP advised Redeeem on the transaction. On May 24, 2021, Troika Media Group acquired Redeeem for $12.3 million, consisting of $1.21 million...
ALT TEX’s Pre-Seed Funding Round
Osler, Hoskin & Harcourt LLP advised ALT TEX in its pre-seed financing. On May 19, 2021, ALT TEX completed its pre-seed funding round co-led by Garage Capital...
Susquehanna Growth Equity’s Investment in LiveBarn
Osler, Hoskin & Harcourt LLP advised Susquehanna in its investment in LiveBarn. On May 11, 2021, LiveBarn, a provider of online broadcasts of amateur & youth...
Agnostiq’s $2 Million Financing Round
Osler, Hoskin & Harcourt LLP advised Agnostiq in its financing. On May 13, 2021, Agnostiq, a Toronto-based software firm specializing in building a development platform for...
Susquehanna Growth Equity’s Investment in LiveBarn
Osler, Hoskin & Harcourt LLP advised Susquehanna in its investment in LiveBarn. On May 11, 2021, LiveBarn, a provider of online broadcasts of amateur & youth...
Tantalus Systems Holding’s Qualifying Transaction with RiseTech Capital Corp.
Osler, Hoskin & Harcourt LLP advised Tantalus Systems Holdings Inc. in its Qualifying Transaction with RiseTech Capital Corp., concurrent $10 million financing and graduation to the...
Acasti Pharma Inc.’s Acquisition of Grace Therapeutics
Osler, Hoskin & Harcourt LLP advised Acasti Pharma on the deal, while Reed Smith advised Grace Therapeutics. Acasti Pharma entered into of a definitive agreement to acquire Grace...
Knix Wear’s $53 Million Financing Round
Osler, Hoskin & Harcourt LLP advised Acton Capital on the deal. On May 18, 2021, Knix Wear completed a $53 million financing round led by TZP...
Knix Wear’s $53 Million Financing Round
Osler, Hoskin & Harcourt LLP advised Acton Capital on the deal. On May 18, 2021, Knix Wear completed a $53 million financing round led by TZP...